Company Filing History:
Years Active: 2004
Title: Innovations by Inventor Qiupang Wang in the Field of MRP1 Inhibition
Introduction
Qiupang Wang is a prominent inventor based in Hamden, Connecticut. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for inhibiting MRP1, a critical factor in drug resistance.
Latest Patents
Wang holds a patent for "Methods and compounds for inhibiting MRP1". This invention focuses on a method of inhibiting MRP1 in mammals, involving the administration of an effective amount of a compound of a specified formula. This innovation holds potential for improving treatment strategies against diseases where MRP1 plays a role in drug resistance.
Career Highlights
Qiupang Wang is associated with Eli Lilly and Company, a global leader in pharmaceutical development. His work at Eli Lilly has likely contributed to the advancement of therapeutic strategies that target multi-drug resistance, showcasing his expertise in medicinal chemistry and pharmaceutical sciences.
Collaborations
Throughout his career, Wang has collaborated with esteemed colleagues such as Rosanne Bonjouklian and Jeffrey Daniel Cohen. These collaborations have been instrumental in enriching his research and enhancing the impact of his inventions within the pharmaceutical community.
Conclusion
The contributions of Qiupang Wang exemplify the vital role of inventors in the pharmaceutical industry. His innovative methods for inhibiting MRP1 represent a significant step forward in addressing drug resistance in treating various medical conditions.